Increasing number of surgical procedures is expected to enhance the growth of infusion pumps market from 2018 to 2025.
The global infusion pumps market is expected to reach US$ 18,045.6 Mn in 2025 from US$ 11,378.8 Mn in 2017. The market is expected to witness growth due to rise in the number of surgical procedures being performed in developing as well as developed nations.
Infusion pumps are used during surgeries to send pain medicine through catheter to a specific part of your body. Infusion pumps can provide targeted and consistent medicine to decrease the pain. They are used when other methods are less effective or when the patient need long-term medicines or fluids. The plastic surgical procedures like liposuction, abdominoplasty, and mammoplasty, require short hospital stay, patients are discharged for ambulatory recovery on oral analgesic management. However, anesthetists have started using infusion pumps to achieve adequate outpatient analgesic control. These pumps continuously administer and maintain constant plasma concentrations. According to the American Society of Plastic Surgeons in 2017, there were around 17.5 million surgical and minimally invasive plastic Also, according to the Centers for Disease Control and Prevention (CDC) every year about 735,000 people in suffer from a heart attack. Furthermore, the Johns Hopkins University has estimated that approximately 84 million people in the US suffer from some form of the cardiovascular disease. This has led to increase in cardiovascular surgeries.
Also, as per the survey “Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes” 312 million major surgical procedures were performed in 2012, an increase of one-third from 2004. The number of surgical procedures are increasing whereas the number of deaths are decreasing. Thus, increasing number of surgical procedures coupled with technological advancements is anticipated to drive the infusion pumps market.
Also, the rising incidences of chronic diseases is anticipated to fuel the growth of the infusion pumps market during the forecast period. Chronic diseases such as, diabetes and congestive heart failure (CHF) have been witnessing a growth in the recent years. Infusion pumps are also used to treat heart failure that helps in relieving and controlling the symptoms. According to Emory Healthcare in 2018, around 5 million people in America suffer from congestive heart failure (CHF). Also, Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications.
Some of the prominent players operating in infusion pumps market are BD, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche Ltd., Medtronic, Baxter International, Inc., Smith Medical, Moog, Inc., ICU Medical, Inc., and Insulet Corporation.
